Intellia Therapeutics Inc (NTLA) Ownership

27.47 ↓0.04 (-0.15%)
As of March 28, 2024, 3:59pm EST.

Institutional Ownership

ARK Investment Management LLC is the biggest individual institutional holder of Intellia Therapeutics Inc (NTLA), owning a total of 11.4 million shares. Combined, the top 30 institutional holders of NTLA own 79.18% of the company with a total of 75 million shares.

In the latest ownership report on December 31st 2023, the top 30 institutional holders increased their combined ownership of NTLA by 4 million shares. 12 institutions bought 5,464,414 total additional shares and increased their ownership by an average of 19.51%. However 8 institutions sold 1,472,214 total shares and decreased their ownership by an average of 8.7%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Intellia Therapeutics increased by a net total of 3,992,200 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Investment Management LLC11.875%14.714%11,412,4491,463,8202023-12-31
BlackRock Inc9.376%10.795%9,010,695877,9052023-12-31
Vanguard Group Inc8.686%1.899%8,347,449155,5792023-12-31
State Street Corporation4.928%26.867%4,735,8611,002,9362023-12-31
Nikko Asset Management Americas Inc3.620%-1.186%3,478,562-41,7332023-12-31
Sumitomo Mitsui Trust Holdings Inc3.620%-1.186%3,478,562-41,7332023-12-31
Morgan Stanley - Brokerage Accounts2.648%-17.662%2,545,022-545,9192023-12-31
Wellington Management Company LLP2.557%-7.356%2,456,917-195,0772023-12-31
Deep Track Capital, LP2.341%12.500%2,250,000250,0002023-12-31
Federated Hermes Inc2.098%13.814%2,016,300244,7222023-12-31
Geode Capital Management, LLC2.053%4.947%1,973,26993,0242023-12-31
T. Rowe Price Associates, Inc.1.909%-10.496%1,834,143-215,0772023-12-31
AllianceBernstein L.P.1.731%7.539%1,663,742116,6302023-12-31
Goldman Sachs Group Inc1.716%107.099%1,649,054852,7912023-12-31
Rokos Capital Management LLP1.523%5.351%1,463,63074,3342023-12-31
Casdin Capital, LLC1.509%23.082%1,450,000271,9252023-12-31
FMR Inc1.235%-20.524%1,186,603-306,4252023-12-31
Dimensional Fund Advisors, Inc.1.218%5.472%1,170,82960,7482023-12-31
Himension Fund1.072%-9.997%1,030,621-114,4702023-12-31
Chevy Chase Trust Holdings, Inc.1.107%-1.175%991,175-11,7802023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Investment Management LLC11.875%14.714%11,412,4491,463,8202023-12-31
BlackRock Inc9.376%10.795%9,010,695877,9052023-12-31
Vanguard Group Inc8.686%1.899%8,347,449155,5792023-12-31
State Street Corporation4.928%26.867%4,735,8611,002,9362023-12-31
Nikko Asset Management Americas Inc3.620%-1.186%3,478,562-41,7332023-12-31
Sumitomo Mitsui Trust Holdings Inc3.620%-1.186%3,478,562-41,7332023-12-31
Morgan Stanley - Brokerage Accounts2.648%-17.662%2,545,022-545,9192023-12-31
Wellington Management Company LLP2.557%-7.356%2,456,917-195,0772023-12-31
Deep Track Capital, LP2.341%12.500%2,250,000250,0002023-12-31
Federated Hermes Inc2.098%13.814%2,016,300244,7222023-12-31
Geode Capital Management, LLC2.053%4.947%1,973,26993,0242023-12-31
Citadel Advisors Llc2.050%22.781%1,970,183365,5552023-09-30
T. Rowe Price Associates, Inc.1.909%-10.496%1,834,143-215,0772023-12-31
AllianceBernstein L.P.1.731%7.539%1,663,742116,6302023-12-31
Goldman Sachs Group Inc1.716%107.099%1,649,054852,7912023-12-31
Viking Global Investors LP1.774%-22.354%1,569,545-451,8652023-03-31
Rokos Capital Management LLP1.523%5.351%1,463,63074,3342023-12-31
Casdin Capital, LLC1.509%23.082%1,450,000271,9252023-12-31
Bank of America Corp1.516%94.987%1,341,093653,3082023-03-31
FMR Inc1.235%-20.524%1,186,603-306,4252023-12-31
Dimensional Fund Advisors, Inc.1.218%5.472%1,170,82960,7482023-12-31
Nuveen Asset Management, LLC1.196%59.321%1,058,218394,0122023-03-31
Himension Fund1.072%-9.997%1,030,621-114,4702023-12-31
Avidity Partners Management LP1.172%-11.206%999,100-126,0942022-09-30
Chevy Chase Trust Holdings, Inc.1.107%-1.175%991,175-11,7802023-12-31
Charles Schwab Investment Management Inc1.077%9.612%952,71783,5452023-06-30
NORGES BANK0.973%94.060%857,278415,5182022-12-31
Northern Trust Corp0.875%9.235%769,86065,0862022-12-31
Two Sigma Advisers, LLC0.909%63.285%715,217277,2002022-06-30
JPMorgan Chase & Co0.817%2.308%642,46414,4952022-06-30

Mutual Fund Ownership

ARK Disruptive Innovation Full Composite is the biggest individual fund holder of Intellia Therapeutics Inc (NTLA), owning a total of 8.1 million shares. Combined, the top 28 mutual fund holders of NTLA own 55.03% of the company with a total of 52.2 million shares.

In the latest ownership report on February 29th 2024, the top 28 fund holders increased their combined ownership of NTLA by 81 thousand shares. 5 funds bought 112,401 total additional shares and increased their ownership by an average of 1.09%. However 3 funds sold 31,093 total shares and decreased their ownership by an average of 0.23%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Intellia Therapeutics increased by a net total of 81,308 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Innovation ETF8.031%-0.249%7,718,173-19,2642024-02-29
SPDR® S&P Biotech ETF3.026%1.903%2,907,78954,3032024-02-29
Vanguard Total Stock Mkt Idx Inv2.738%-0.434%2,631,770-11,4762024-02-29
ARK Genomic Revolution ETF2.445%0.508%2,350,13611,8802024-02-29
Vanguard Small Cap Index2.282%0.934%2,192,90220,2892024-02-29
iShares Russell 2000 ETF2.245%-0.016%2,157,747-3532024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.372%0.420%1,318,4755,5192024-02-29
Vanguard Small Cap Growth Index Inv1.281%1.686%1,230,77520,4102024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Disruptive Innovation Full Composite8.386%18.815%8,059,5331,276,2942023-12-31
ARK Innovation ETF8.031%-0.249%7,718,173-19,2642024-02-29
SPDR® S&P Biotech ETF3.026%1.903%2,907,78954,3032024-02-29
Vanguard Total Stock Mkt Idx Inv2.738%-0.434%2,631,770-11,4762024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr2.955%6.569%2,614,702161,1642023-03-31
ARK Genomic Revolution2.519%19.216%2,421,325390,2892023-12-31
ARK Genomic Revolution ETF2.445%0.508%2,350,13611,8802024-02-29
Nikko AM ARK Disruptive Innovation A USD2.371%0.000%2,278,21002024-01-31
Vanguard Small Cap Index2.282%0.934%2,192,90220,2892024-02-29
iShares Russell 2000 ETF2.245%-0.016%2,157,747-3532024-02-29
Vanguard Health Care Inv1.597%0.000%1,534,65102023-12-31
Vanguard Institutional Extnd Mkt Idx Tr1.372%0.420%1,318,4755,5192024-02-29
Vanguard Small Cap Growth Index Inv1.281%1.686%1,230,77520,4102024-02-29
Vanguard Extended Market Index Investor1.386%-0.018%1,226,007-2252023-08-31
Federated Hermes Kaufmann Small Cap Grow1.042%3.946%1,001,00038,0002023-12-31
Federated Hermes Kaufmann Small Cap A1.042%3.946%1,001,00038,0002023-12-31
Federated Hermes Kaufmann R1.030%25.559%990,000201,5232023-12-31
Federated Hermes Kaufmann Growth1.030%25.559%990,000201,5232023-12-31
Fidelity Small Cap Index0.913%1.297%877,41411,2382023-12-31
Fidelity® Small Cap Index0.949%2.745%849,80622,7042023-10-31
US Small-Cap Growth II Equity Comp0.862%-9.497%828,664-86,9552023-12-31
T. Rowe Price New Horizons0.862%-9.497%828,664-86,9552023-12-31
Fidelity Select Biotechnology0.857%0.000%823,50102024-01-31
Fidelity® Select Biotechnology0.920%0.000%823,50102023-11-30
Nikko AM ARK Pstv Chg Innovt P JPY Acc0.912%0.000%816,77602023-11-30
iShares Biotechnology ETF0.712%0.064%606,7643882023-01-31
Fidelity® Contrafund®0.638%-0.056%543,746-3062022-11-30
AB Small Cap Growth A0.631%5.819%537,56629,5602022-11-30

Discussions

Please log in or register to share your thoughts.

iphonepromax

$NTLA one of the poorest performed stocks for a big name.

0 Like Report